These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 3938978)
1. Meningococcal vaccines in prevention and control of meningitis. Saxena SN; Rawal IJ; Tripathi KK; Gupta P Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978 [No Abstract] [Full Text] [Related]
2. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
3. Right age for Meningococcal vaccine. John TJ Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680 [No Abstract] [Full Text] [Related]
4. [Vaccines against Neisseria meningitidis]. Ferrón L; Criado MT; Ferreirós CM Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002 [No Abstract] [Full Text] [Related]
5. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation]. Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465 [TBL] [Abstract][Full Text] [Related]
6. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Wahdan MH; Sallam SA; Hassan MN; Abdel Gawad A; Rakha AS; Sippel JE; Hablas R; Sanborn WR; Kassem NM; Riad SM; Cvjetanović B Bull World Health Organ; 1977; 55(6):645-51. PubMed ID: 413639 [TBL] [Abstract][Full Text] [Related]
7. Vaccines against meningococcal meningitis: current status. Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300 [No Abstract] [Full Text] [Related]
8. Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates. Sivonen A J Infect; 1981 Sep; 3(3):266-72. PubMed ID: 6821094 [No Abstract] [Full Text] [Related]
10. [Serogroup A N. meningitidis polysaccharide vaccine and serogroup A N. meningitidis carrier state (author's transl)]. Bencić Z; Madarić D; Manhalter T; John V; Amsel V; Weisglass H Lijec Vjesn; 1978 Nov; 100(11):706-7. PubMed ID: 107385 [No Abstract] [Full Text] [Related]
11. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis]. Xu CH Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030 [No Abstract] [Full Text] [Related]
12. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic]. Wu C Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683 [No Abstract] [Full Text] [Related]
13. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report. Lepow ML; Gold R N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865 [No Abstract] [Full Text] [Related]
14. [Meningococcal disease in the Netherlands; after low tide another high tide?]. Zanen HC Ned Tijdschr Geneeskd; 1984 Mar; 128(11):515-8. PubMed ID: 6424036 [No Abstract] [Full Text] [Related]
15. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa]. Chippaux JP; Debois H; Saliou P Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963 [TBL] [Abstract][Full Text] [Related]
17. Development and use of meningococcal vaccines. Artenstein S Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):127-32. PubMed ID: 4213026 [No Abstract] [Full Text] [Related]
18. Status of a group B Neisseria meningitidis vaccine. Frasch CE Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731 [No Abstract] [Full Text] [Related]
19. Susceptibility to meningococcal meningitis. Sabath LD; Rosner B N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552 [No Abstract] [Full Text] [Related]